Pasithea Therapeutics Corp. (KTTAW) Invested Capital (2022 - 2023)

Pasithea Therapeutics has disclosed Invested Capital across 2 years of filings, most recently posting $35.7 million for Q2 2023.

• In Q2 2023, Invested Capital changed N/A year-over-year to $35.7 million; the TTM figure through Jun 2023 stood at $35.7 million (changed N/A YoY), while the FY2022 annual figure was $42.5 million, changed N/A from the prior year.
• Invested Capital came in at $35.7 million for Q2 2023 at Pasithea Therapeutics, down from $39.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $42.5 million in Q4 2022 to a low of $35.7 million in Q2 2023.